Table 2.
Univariable | Multivariablea | |||||||
---|---|---|---|---|---|---|---|---|
Event | Regimen type | N Events | IRR | (95% CI) | P Value | IRR | (95% CI) | P Value |
Death | 3DR | 186 | 1 | 1 | ||||
2DR | 18 | 0.90 | (.55–1.46) | .66 | 0.69 | (.42–1.12) | .13 | |
Non-AIDS–defining cancer | 3DR | 130 | 1 | 1 | ||||
2DR | 26 | 1.86 | (1.22–2.84) | .004 | 1.35 | (.88–2.09) | .17 | |
Cardiovascular disease | 3DR | 109 | 1 | 1 | ||||
2DR | 14 | 1.19 | (.68–2.08) | .54 | 0.80 | (.45–1.41) | .44 | |
AIDS, noncancer | 3DR | 80 | 1 | 1 | ||||
2DR | 11 | 1.28 | (.68–2.40) | .44 | 1.27 | (.67–2.43) | .47 |
Abbreviations: 2DR, 2-drug regimen; 3DR, 3-drug regimen; CI, confidence interval; IRR, incidence rate ratio.
aMultivariable model adjusted for age, CD4 cell count at regimen start, smoking status, and number of drugs previously exposed to.